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Abstract
Failure to establish an appropriate balance between pro- and anti-inflammatory immune responses is believed to contribute
to pathogenesis of severe malaria. To determine whether this balance is maintained by classical regulatory T cells (CD4+
FOXP3+ CD1272/low; Tregs) we compared cellular responses between Gambian children (n = 124) with severe Plasmodium
falciparum malaria or uncomplicated malaria infections. Although no significant differences in Treg numbers or function
were observed between the groups, Treg activity during acute disease was inversely correlated with malaria-specific
memory responses detectable 28 days later. Thus, while Tregs may not regulate acute malarial inflammation, they may limit
memory responses to levels that subsequently facilitate parasite clearance without causing immunopathology. Importantly,
we identified a population of FOXP32, CD45RO+ CD4+ T cells which coproduce IL-10 and IFN-c. These cells are more
prevalent in children with uncomplicated malaria than in those with severe disease, suggesting that they may be the
regulators of acute malarial inflammation.
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Introduction
The clinical spectrum of P. falciparum infection ranges from
asymptomatic parasite carriage to a febrile disease that may
develop into a severe, life-threatening illness. The factors that
determine disease severity are not completely understood but are
likely to include both parasite and host components [1–3].
Ultimately, the interplay between the parasite and the immune
response likely determines the outcome of the infection [4].
Although sterile immunity - completely preventing re-infection - is
hardly ever seen and protection against clinical symptoms of
uncomplicated disease is only acquired after repeated infections
[5], immunity to severe disease and death may be acquired after as
few as one or two infections [6] suggesting that different immune
mechanisms underlie these different levels of immunity.
While there is a growing consensus that killing of malaria
parasites or malaria-infected red blood cells requires the synergistic
action of antibodies and cell-mediated immune responses [5,7],
the mechanisms conferring protection against severe disease are
less clear. Given that pathology of severe disease has repeatedly
been linked to sustained and/or excessive inflammatory responses
[4], acquiring the ability to regulate these responses adequately
may be a key determinant of immunity that protects against severe
disease [8]. Thus, while an early inflammatory response is needed
to control parasite replication in human P. falciparum malaria [9–
11], excessive levels of pro-inflammatory cytokines such as TNF-a
[12–15], IFN-c, [16,17], IL-1b and IL-6 [14,18,19] are associated
with severe pathology. Conversely, low levels of regulatory
cytokines such as TGF-ß have been associated with acute [20]
and severe malaria [21,22], a relative deficiency in IL-10 was seen
in those who succumbed to severe malaria [23], significantly lower
ratios of IL-10 to TNF-a were found in patients with severe
malarial anaemia [24,25], and high ratios of IFN-c, TNF-a and
IL-12 to TGF-b or IL-10 were associated with decreased risk of
malaria but increased risk of clinical disease in those who became
infected [26]. In summary, therefore, immunity against severe
malaria may depend upon the host’s ability to regulate the
magnitude and timing of the cellular immune response, allowing
the sequential induction of appropriate levels of inflammatory- and
anti-inflammatory cytokines at key stages of the infection.
Given these associations between severe disease and exacerbat-
ed immune pathology, a number of studies have explored the role
of CD4+CD25hiFOXP3+CD1272/lo regulatory T cells (Tregs) in
determining the outcome of malaria infection. Induced and/or
activated in response to malaria infection [27], Tregs may be
beneficial to the host in the later part of the infection - when
parasitaemia is being cleared - by down-regulating the inflamma-
tory response and thereby preventing immune-mediated pathol-
ogy. On the other hand, if Tregs mediate their suppressive effects
too early, this could hamper the responses required for initial
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control of parasitaemia, permitting unbridled parasite growth
which may also lead to severe disease. Malaria-specific induction
of Tregs has been observed in a variety of experimental malaria
infections in mice [28–31], but their role in preventing severe
malarial pathology is unclear. Thus, in BALB/c mice infected with
a lethal strain of P. yoelii, ablation of Treg activity by depletion of
CD25+ cells either allowed mice to control parasitaemia and
survive [32] or had no impact on the course of disease [33].
Depleting CD25+ cells of BALB/c mice infected with either P.
berghei NK65 [34] or P berghei ANKA [35] reduced neither
parasitaemia nor mortality, but increased the severity of symptoms
in the diseased mice, suggesting at least some benefit from Tregs in
this model. Rather oddly, infection of CD25+ T cell-depleted
BALB/c mice with P. chabaudi adami DS led to increased
parasitaemia and more severe anaemia [30]. Finally, CD25+ T
cell depletion around the time of parasite inoculation reduced the
incidence of experimental cerebral malaria in C57BL/6 mice
infected with P. berghei ANKA in two independent studies [29,31],
but not when CD25+ T cells were depleted 30 days prior to
infection [31]. Whilst various explanations have been offered for
these discrepant results, including differences in the various strains
of mice and parasites employed, the microbial microenvironment
in which the mice are kept, and the precise CD25 depletion
protocols employed, these studies are currently not very helpful
when trying to understand the role of Tregs in human malaria
infections.
Malaria naı¨ve individuals undergoing experimental P. falciparum
sporozoite infection showed an increase in FOXP3 mRNA
expression and expansion of Tregs 10 days after infection; Treg
induction correlated with high circulating levels of TGF-b, low
levels of pro-inflammatory cytokines and rapid parasite growth
[27] suggesting - but not proving - that Treg activation early in
infection may inhibit the development of effective cellular
immunity. More recently, we have observed that Treg populations
appear to be transiently expanded and activated during the
malaria transmission season in individuals from a malaria endemic
community [36], again suggesting that naturally acquired malaria
infection can drive the expansion and activation of Tregs.
However, although Tregs have been implicated in IL-10-mediated
down-regulation of Th1-like responses in the placenta of malaria-
infected women [37] and reduced Treg frequencies and function
have been linked to enhanced anti-parasite immunity in certain
ethnic groups in West Africa [38] the potential for Tregs to
influence the clinical outcome of malaria infections is still unclear.
To investigate the role of Tregs during clinical malaria
infection, we have compared cellular immune responses of
children with either severe or uncomplicated malaria. Interesting-
ly, although we did not observe any significant differences in Treg
numbers or function between severe and uncomplicated malaria
cases, our data do indicate that malaria-induced Tregs may limit
the magnitude of malaria-specific Th1 memory responses and thus
moderate pro-inflammatory responses to subsequent infections,
providing a possible explanation for the very rapid acquisition of
immunity to severe malaria. Moreover, we have identified a
population of FOXP32, CD45RO+, CD4+ T cells which co-
produce IL-10 and IFN-c and which are more prevalent in
children with uncomplicated malaria than in those with severe
disease. We suggest that these IL-10 producing effector T cells
may contribute to clearing malaria infection without-inducing
immune-mediated pathology.
Results
Immune responses of 59 Gambian children with severe P.
falciparum malaria were compared with those of 65 children with
uncomplicated clinical malaria and with 20 healthy (control)
children of similar age and recruited from the same study area at
the same time (Table 1). On admission, only 12 (9.4%) patients
had a white blood cell count (WBC) above the age-specific norm
and there was no significant difference in median WBC count
between uncomplicated and severe cases, suggesting that few if any
children had a concomitant systemic bacterial infection. No
difference was observed in the differential WBC between the two
groups. As expected, [39–41] numbers of lymphocytes, CD3+ and
CD4+ T cells were significantly lower during the acute disease
than during convalescence in both the severe and the uncompli-
cated groups (Table 1A). Parasite density on admission was two-
fold higher in patients with severe malaria than in those with
uncomplicated malaria; severely ill children also had significantly
lower hemoglobin levels and were on average 2.4 years younger
than children with uncomplicated disease. The number of P.
falciparum clones per clinical isolate ranged from 1 to 4 (with an
overall mean of 2 (CI95%: 1.8–2.1)), and – as has been observed
previously [42] - did not differ significantly between the three
groups (p = 0.3, Table 1B). Other factors potentially confounding
immune responses, such as the degree of malnutrition or intestinal
helminth infections were of similarly low prevalence in both severe
and uncomplicated malaria cases and were not associated with
severity of disease (Table 1B).
For statistical analysis, patients were classified as uncomplicated
or severe cases, with the latter being further subdivided into those
patients suffering from cerebral malaria (CM), severe anaemia (SA)
or severe respiratory distress (SRD) (grouped together as SA) and
those suffering only from severe prostration (grouped as SB). Data
were analysed using linear regression, with a random effect to
allow for the within subject measurements over time, adjusting for
age, sex, duration of prior symptoms and numbers of clones
causing the infection. Due to the multiplicity of comparisons that
were made within the model, resulting from multiple responses
and multiple comparisons within response, hypotheses rejected
with a probability of less than 0.012 have a false discovery rate of
5% [43].
Author Summary
While Tregs have been implicated in regulation of the
immune response to chronic infections, their potential in
determining disease outcome in acute infections is
unclear. In this study we have found that Tregs are unable
to control the florid inflammation during acute, severe P.
falciparum malaria infections, suggesting that this compo-
nent of the immunoregulatory arsenal may be rapidly
overwhelmed by virulent infections. Further, we identified,
for the first time in an acute human infection, a population
of IL-10-producing Th-1 effector cells and found that IL-10-
producing Th-1 cells were associated with development of
uncomplicated as opposed to severe malaria, leading us to
suggest that such ‘‘self-regulating’’ Th-1 cells may contrib-
ute to clearing malaria infections without inducing
immune-mediated pathology. In addition, we found
evidence that malaria-induced Tregs may limit the
magnitude of malaria-specific memory responses detect-
able 28 days later, which may reduce the risk of immune-
mediated pathology upon reinfection and may explain
how immunity to severe disease can be gained after as
little as one or two infections. We conclude that vaccines
designed to induce cell-mediated responses should be
assessed for their ability to induce IL-10 producing Th-1
cells and Tregs.
FOXP3+ and FOXP32 CD4+ T cells in Acute Malaria
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Similar numbers and proportions of Tregs among
uncomplicated and severe malaria cases, increasing
during convalescence
We hypothesized that children with severe malaria would have
fewer circulating Tregs than children with uncomplicated malaria,
or that Tregs of severely ill children would be less active than those
of children with uncomplicated disease. However, the proportion
of cells expressing a Treg phenotype (defined by flow cytometry as
CD3+CD4+ lymphocytes being FOXP3+and CD1272/low;
Figure 1A, 1B, and 1C) was similar in the acute (D0) and the
convalescent phase (D28) for both uncomplicated and severe cases
(SA+SB) and in healthy control children; on average, 2–3% of
CD4+ T cells expressed the regulatory phenotype (Figure 1D).
However, when the number of cells expressing a Treg phenotype
was calculated using lymphocyte and monocyte counts from the
differential WBC, we found that the absolute numbers of Tregs
(per litre of blood) were significantly and similarly elevated in both
severe and uncomplicated malaria cases during convalescence
when compared to the acute phase (p,0.001) or when compared
to the control group of healthy children (p = 0.037) (Figure 1E). A
similar kinetic was observed for FOXP3 mRNA levels (Figure 1F).
Although not supportive of our original hypothesis, these
observations are consistent with the notion that acute malaria
infection drives expansion of Treg populations which then persist
for some weeks to maintain immune homeostasis during the
contraction phase of the effector response [36]. In accordance with
this notion, and in agreement with our previous observation that
increased levels of Tregs were associated with faster parasite
growth during the early stages of blood stage infection [27], we
observe here in - children with either severe or uncomplicated
malaria infections - a significant positive correlation between
parasite density and the frequency of Tregs within the CD4+ T cell
population (p = 0.002, Figure 2).
Tregs display an activated memory phenotype during
acute disease
Since fully differentiated Tregs predominantly express an
activated/memory phenotype [44] T cells from children with
severe and uncomplicated malaria were analysed for expression of
CD45RO (Figure 3A and 3B). In both uncomplicated and severe
cases, the proportion of all T cells expressing CD45RO was
significantly higher (p,0.001) during acute infection than during
convalescence (data not shown). Irrespective of disease severity,
more than 90% of Tregs expressed CD45RO during the acute
phase of infection but expression of this marker decreased
significantly (to approx 70%) during convalescence (Figure 3C).
Likewise, the median fluorescence intensity (MFI) of CD45RO
staining was 1.5 fold higher (p = 0.0025) during acute disease than
during convalescence (Figure 3D). Taken together, these data
indicate that in both uncomplicated and severe cases of malaria
Table 1. Characteristics of study participants (A) and distribution of potential confounding factors (B).
A) Day 0 Day 28 p value p value
Severe Uncomplicated Severe Uncomplicated
Severe vs.
Uncompl D0 vs. D28
WBC [610e9/L] 9 (8.1–10.2) 7.3 (6.6–8.1) 7.5 (6.8–8.3) 6.6 (6.0–7.3) 0.199 0.116
Lymphocytes [610e6/L] 2479 (2178–2821) 2286 (1926–2653) 3715 (3225–4230) 3289 (2826–3693) 0.638 ,0.001
CD3+ PBMC [610e6/L] 1761 (1439–2448) 1642 (1398–1922) 2998 (2291–3594) 2688 (2354–3034) 0.489 ,0.001
CD4+ PBMC [610e6/L] 958 (766–1378) 935 (798–1089) 1522 (1202–1859) 1389 (1216–1590) 0.721 ,0.001
Neutrophils [610e6/L] 5536 (4761–6232) 4418 (3781–5056) 3207 (2822–3635) 2745 (2480–3063) 0.131 ,0.001
Monocytes [610e6/L] 567 (494–652) 444 (393–504) 500 (445–558) 446 (398–496) 0.201 0.928
Platelets [610e3/ml] 61 (48–91) 109 (96–128) 262 (221–301) 267 (248–290) ,0.001 ,0.001
Hb [g/dl] 10.1 (9.45–10.6) 11.7 (11.3–12.1) 11.6 (11.2–12.1) 11.9 (11.6–12.3) 0.01 0.453
GMa parasitaemia [/ml] 270,236 (210,693–346,606) 136,142 (96,924–191,228) 0.008
Age [years] 4.4 (3.9–5.1) 6.7 (5.8–7.7)
Weight [kg] 14.8 (13.5–16.5) 22 (19.3–25.4)
B) Day 0 Day 28 p value
Severe Uncomplicated Severe Uncomplicated Severe vs. Uncompl
Number of participants [n] 59 65 48 (81.4%) 56 (86%)
z score 21.77 (22.2 to 21.31) 21.39 (21.71 to 21.06) 0.19
Intestinal helminths 6.5% (1.8–20.7%) 5.5% (1.9–14.9%) 0.59
Sickle cell trait 5.3% (1.8–14.4%) 5.0% (1.7–13.7%) 0.636
Cough on presentation 27.1% (17.4–39.6%) 26.2% (17–38%) 0.532
Prior antimalarial treatment 34.5% (23.4–7.7%) 37.5% (26.7–49.7%) 0.444
Number of parasite clones 1.9 (1.65–2.07) 2.0 (1.81–2.27) 0.23
aGeometric mean.
Unless otherwise indicated, the median with a 95% CI is given for severe and uncomplicated cases for day 0 (left) and day 28 (right). P values for variables shown in part
(A) are derived from the random effects linear regression model. Part (B) shows z-scores compared using Mann-Whitney test, and proportions for qualitative variables
not included in the model, compared using Chi-square test.
doi:10.1371/journal.ppat.1000364.t001
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Tregs are predominantly of a memory phenotype and are
activated during acute malaria infection.
Similar Treg function in uncomplicated and severe
malaria patients
Three different indicators were used to assess the regulatory
potential of Tregs during acute malaria infection. Firstly, using a
classical anti-CD25 depletion assay, we assessed the ability of
Tregs to suppress P. falciparum shizont extract (PfSE)-driven
lymphocyte proliferation. Anti CD25 treatment removed approx-
imately half (geometric mean 48.8%; CI95%: 41–58%) of the
CD4+ T cells that were FOXP3+CD1272/low and this was
associated with a 1.76 fold and 1.57-fold (geometric means)
increase in PfSE-induced lymphoproliferation in severe and
Figure 1. Similar number and proportion of Tregs in uncomplicated and severe disease, increasing during convalescence. Tregs were
defined as CD3+CD4+PBMC being FOXP3+and CD1272/low. (A) CD3+ viable PBMC were displayed according to CD4 and FOXP3 and FOXP3 positive
cells were defined on contour display as cells above the 90% contour level. (B) CD3+CD4+FOXP3+ PBMC were displayed according to CD127
expression to define the CD127 low cut off. (C) both gates were applied to CD3+CD4+ PBMC. (D) The percentage of Tregs for severe cases is shown for
the subgroup (SA) comprising cases with CM (triangles), SA (squares) and SRD (circles), for the subgroup with severe prostration (SB), and for
uncomplicated cases (U) for days 0 (D0) and 28 (D28) and compared to healthy controls of a similar age range recruited from the study area at the
same time. (E) absolute numbers of cells expressing a Treg phenotype. (F) FOXP3 mRNA levels expressed as a ratio to the house keeping gene 18s
rRNA. Dots represent individual data; bars represent the median. P-values are derived from the random effects linear regression model, adjusting for
age, sex, duration of symptoms and numbers of clones isolated.
doi:10.1371/journal.ppat.1000364.g001
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uncomplicated cases, respectively, with no significant difference
between the groups (p = 0.343, Figure 4A).
Next, since reduced expression of SOCS-2, a member of the
suppressors of cytokine signaling family confined to Tregs [45], has
been linked to impaired Treg function in Africans [38] we
compared SOCS-2 mRNA levels among severe and uncomplicated
cases. While SOCS-2 levels were found to be significantly reduced
during acute disease compared to convalescence (p = 0.0076), no
difference was observed between those with severe and those with
uncomplicated malaria (data not shown).
Finally, since high concentrations of TNF-a have been reported
to impair Treg activity (by upregulating and then signaling via
TNFR2, leading to decreased FOXP3 mRNA and protein
expression [46]), and the functional impairment of Tregs observed
in rheumatoid arthritis patients can be reversed by anti-TNF-a
antibodies [47], we considered the hypothesis that the high levels
of TNF-a seen in severe malaria patients [13,15], might
upregulate TNFR2 and impair Treg function. TNFR2 expression
on Tregs was assessed by flow cytometry (Figure 4B and 4C).
However, although a significantly higher proportion of Tregs
expressed TNFR2 (Figure 4D) - with higher MFI (data not shown,
p = 0.028) - during acute disease compared to convalescence, no
difference was seen in TNFR2 expression on Tregs between severe
and uncomplicated cases (Figure 4D). Moreover, there was no
correlation between plasma levels of TNF-a and TNFR2
expression on Tregs, neither among severe or uncomplicated
cases nor among all cases combined; neither did we observe any
inverse correlation between TNF-a concentration and FOXP3
expression. Rather, the MFI of TNFR2 on Tregs was positively
correlated with the MFI of FOXP3 in Tregs (r: 0.476; p,0.0001).
Thus, our data seem to be more in line with data from mice
suggesting that the interaction of TNF-a with TNFR2 on Tregs
promotes their expansion and upregulation of FOXP3 [48] than
with the data from studies of human rheumatoid arthritis.
Stronger Th-1 responses observed in severe compared to
uncomplicated cases are balanced by IL-10
Since the balance of T-effector to Treg responses is likely to be
as important, or more important, than the absolute levels of either
[26], we compared the ratio of the levels of mRNA for the Th1
transcription factor T-BET with those for FOXP3, currently
considered the best marker for Tregs, and the ratio of T-effector
cells (defined as CD3+CD4+CD25+FOXP32, T-effector) over
Tregs among the various groups. As shown in Figure 5A, in all
groups the T-BET/FOXP3 ratio was significantly higher during
acute disease than during convalescence and a similar, albeit not
significant, trend was observed for the ratio of T-effector/Tregs
(data not shown). Moreover, since the absolute number of
circulating T-effector cells was significantly higher in severe cases
than in uncomplicated cases (p = 0.01, data not shown), the T-
effector/Treg ratio tended to be higher among severe cases than
uncomplicated cases on day 0 (p = 0.039) and a similar trend was
seen for the T-BET/FOXP3 ratio (p = 0.058). The ratio of FOXP3
to GATA-3 (Th2 lineage factor) mRNA was similar for both time
points in all groups (data not shown) but the Th1/Th2 ratio (T-
BET/GATA-3 mRNA) was significantly higher during acute
disease in children with CM, SA or SRD compared to those
suffering from severe prostration (p = 0.0075), indicating that the
expansion of the T-effector population is biased towards Th1
responses.
These data confirm previous studies indicating a shift towards a
more inflammatory response during acute and severe malaria but,
significantly, our data extend the previous observations by
revealing that this inflammation is not balanced by a commen-
surate increase in Treg function. Indeed, our data strongly suggest
that the potent inflammation induced during an acute malaria
infection overwhelms the normal homeostatic capacity of the
immune system and, in particular, that the Treg response in
children with severe malaria is insufficient to balance a much
stronger Th1 effector response.
To investigate further the dynamics of pro-inflammatory/
regulatory responses during clinical malaria, plasma concentra-
tions and mRNA transcripts of inflammatory (IFN-c, TNF-a) and
regulatory cytokines (IL-10) were assayed. In accordance with
previous observations, plasma concentrations of IFN-c, TNF-a
and IL-10 were all significantly higher during acute disease than
during convalescence, with significantly higher levels in severely ill
children compared to uncomplicated cases (Figure 5B, 5C, and
5D). Levels of mRNA transcripts for IL-10 and IFN-c were also
significantly elevated in all groups during acute disease, but there
was no significant difference between severity groups (Figure S1A
and S1B). For both severe and uncomplicated cases, levels of IFN-c
mRNA were highly correlated with levels of IL-10 mRNA during
the acute phase (severe: r = 0.833 p,0.001, uncomplicated:
r = 0.693 p,0.001), suggesting that IFN-c production is being
balanced by IL-10 production. Interestingly, IFN-c mRNA levels
on day 0 correlated with FOXP3 mRNA on day 0 for both severe
(r: 0.39 p = 0.003) and uncomplicated cases (r: 0.44 p = 0.0001),
suggesting that IFN-c may also be driving FOXP3 expression.
The balance of pro-and anti inflammatory cytokine responses
clearly changed with time, but somewhat surprisingly, there were
no marked differences in cytokines ratios between children with
differing levels of disease severity. Thus, the ratios of TNF-a or
IFN-c to IL-10 on day 0 were similar in all disease severity groups
(Figure 5E and 5F) and ratios of IFN-c to IL-10 mRNA were
similar in all disease severity groups both on day 0 and day 28
(Figure S1F). However, IFN-c mRNA levels were on average only
3.2-fold higher on day 0 than day 28 but IL-10 mRNA levels were
Figure 2. Proportion of T cells expressing a Treg phenotype
correlates with parasitaemia. Parasite density in peripheral blood is
plotted against the proportion of Tregs. +: severe cases; #:
uncomplicated cases. P value for linear regression ignoring disease
status: 0.002. (gradient for separate lines for uncomplicated and severe
cases not significantly different).
doi:10.1371/journal.ppat.1000364.g002
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29-fold higher on day 0, resulting in a significantly lower IFN-c/
IL-10 mRNA ratio on day 0 than day 28 (Figure S1F).
CD252FOXP32 CD45RO+ T cells but not Tregs are the
major source of IL-10 during acute malaria
IL-10 is a crucial immunoregulatory cytokine in both human
[23] and murine [33,49] malaria; we have recently identified
CD4+ T effector cells as a major source of IL-10 [33], but the
source of IL-10 in human malaria infection is unknown. In other
protozoal infections of mice CD4+ effector T cells that co-produce
IFN-c and IL-10 have been identified [50–52]. We therefore
cultured freshly isolated PBMCs from 30 children with acute
malaria (17 severe, 13 uncomplicated) and 20 healthy control
children, with or without PMA and Ionomycin (PI), for 5 hours
and analyzed them for the presence of intracellular IL-10 and
IFN-c by flow cytometry (Figure 6A). No cytokine production was
observed in unstimulated cells (data not shown), and PBMC from
healthy children failed to produce any IL-10 in response to PI
(data not shown), indicating that stimulation with PI predomi-
nantly induces cytokine production from recently activated cells.
By contrast, distinct populations of IL-10+ and IFN-c+ cells were
seen among the PI-stimulated cells from children with acute severe or
uncomplicated malaria, with a small but easily distinguishable
population of cells (approx 1% of all PBMC) producing both cytokines
simultaneously (Figure 6A, right plot). In both severe and uncompli-
cated cases, IL-10 producing cells were predominantly CD45RO+
CD4+ T cells (Figure 6B and 6C) and were almost exclusively
FOXP32 and CD252 (Figure 6D). Moreover, although a transient
increase of FOXP3 in activated human T-effector cells has been
reported [53], in our hands less than 1% (median 0.97%, CI95%:
0.67–1.27%) of IFN-c producing cells were FOXP3+ (Figure 6E).
Overall, among children with acute malaria, approx 4% of PI-
stimulated CD4+ T cells produced IL-10 and approx 8% produced
IFN-c and neither the proportions of cells producing one or the
other cytokine (Figure 6F) nor the ratio of IFN-c/IL-10 producing
cells (data not shown) differed significantly between severe and
uncomplicated cases. However, intriguingly, the proportion of
CD4+ T cells simultaneously producing IL-10 and IFN-c was
three fold higher in uncomplicated cases than severe cases
(geometric mean 5.2% vs 1.6%, p = 0.041, Figure 6F). Moreover,
the proportion of IFN-c+ CD4+ T cells that also produce IL-10
was almost twice as high among uncomplicated cases as among
severe cases (p = 0.045, Figure 6G).
Taken together, these data indicate that during acute,
uncomplicated or severe, malaria infections IL-10 producing cells
are overwhelmingly T effector cells and that Th1 effector cells that
also produce IL-10 are more prevalent in children with
uncomplicated malaria than in children with severe malaria.
Figure 3. Tregs display an activated memory phenotype during acute disease. (A) Defining the gate for CD45RO staining on CD3+ PBMC
using the contour display. (B) CD3+CD4+FOXP3+ CD1272/low PBMC displayed according to CD45RO expression using the gate defined in (A). (C)
percentage of CD3+CD4+FOXP3+ CD1272/low PBMC expressing CD45RO. (D) Median Fluorescence Intensity (MFI) for CD45RO staining on
CD3+CD4+FOXP3+ CD1272/low PBMC. Symbols, bars and p-values as defined in Figure 1.
doi:10.1371/journal.ppat.1000364.g003
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The frequency of Tregs during acute disease is negatively
associated with the magnitude of subsequent malaria-
specific IFN-c memory responses
It has been reported that Tregs present at the time of infection
[54] or vaccination [55] may restrict the development of
subsequent Th1 memory responses. To determine whether Tregs
present during acute malaria infection might similarly affect the
induction of immunological memory, we compared FOXP3
mRNA levels on day 0 with malaria specific IFN-c memory
responses (as assessed by PfSE-specific cultured ELISPOT) among
PBMC collected from 34 of our convalescent malaria patients (19
severe and 15 uncomplicated) on Day 28.
As shown in Figure 7A, cells from uncomplicated and severe
cases mounted similarly strong IFN-c memory responses following
culture with PfSE. When plotted against FOXP3 mRNA levels
measured on day 0, a linear by linear hyperbolic fit revealed that
higher levels of FOXP3 mRNA on day 0 were highly significantly
(p = 0.009) associated with lower malaria-specific IFN-c memory
responses on Day 28, suggesting that Tregs induced during the
acute infection may limit the magnitude of subsequent Th1
responses (Figure 7B). For neither group could a significant effect
of parasitaemia on the memory response be observed (r =20.12
p = 0.962 for severe and r = 0.015, p = 0.957 for uncomplicated
cases).
Discussion
We hypothesized that the balance of inflammatory to regulatory
immune responses would be biased towards a more inflammatory
response in children with severe malaria than in children with
uncomplicated malaria, that this balance would be restored during
convalescence and – crucially – that this would be associated with
differences in the proportion, absolute number or function of
circulating classical (CD4+ CD1272/lo FOXP3+) regulatory T
cells. In partial support of these hypotheses, the number of cells
expressing a Treg phenotype and FOXP3-mRNA levels were both
significantly higher during convalescence than during the acute
clinical episode and the ratio of the Th1 transcription factor T-
BET to the Treg transcription factor FOXP3 was significantly
higher during acute disease than during convalescence in both
severe and uncomplicated cases, compatible with the notion that
Tregs fail to sufficiently regulate pro-inflammatory responses
which might contribute to the onset of symptomatic malaria
infection.
Given our previous observation of Treg expansion during the
pre-patent phase of malaria infection [27], we suggest that Tregs
are induced/activated shortly after parasite emergence from the
liver, that their numbers in peripheral blood then decline as a
result of sequestration of CD4+ T cells during acute disease
[40,41,56] and then, as has been described for other T cell subsets
[39,57], Tregs regain access to the circulation after malaria is
cured. The significant positive correlation of Treg numbers with
parasitaemia, as well as the correlation between FOXP3 mRNA
and IFN-c mRNA levels in acute samples, further supports the
notion that the initial infection induces a proportional increase in
Figure 4. Tregs from severe and uncomplicated cases have
similar functional capacity. (A) PBMC from 10 severe and 10
uncomplicated cases collected on day 0 were depleted of CD25+hi cells
or mock depleted using magnetically labelled beads (Dynal), and
assessed for proliferation using [3H]-thymidine after 6 days in culture
with P. falciparum shizont extract (PfSE), uninfected red blood cells
(uRBC), PMA+Ionomycin (P+I), or growth medium (GM), respectively.
The geometric mean fold increase in proliferation with 95% CI is shown
for the stimulation index of
PfSE=uRBC CD25zhi depletedð Þ
PfSE=uRBC mock-depletedð Þ (black
bars) or
PzI=GM CD25zhi depletedð Þ
PzI=GM mock depletedð Þ (white bars). (B) Representative
examples of TNFR2 expression on PBMC, and (C) on Tregs. (D) Proportion
of Tregs that express TNFR2. Symbols, bars and p-values as defined in
Figure 1.
doi:10.1371/journal.ppat.1000364.g004
FOXP3+ and FOXP32 CD4+ T cells in Acute Malaria
PLoS Pathogens | www.plospathogens.org 7 April 2009 | Volume 5 | Issue 4 | e1000364
Tregs, attempting to balance the effector T cell response, and is in
line with the recently proposed concept that antigenic challenge
will give rise to an antigen specific Treg response, proportional in
size to the inflammatory response [58]. Moreover, the Tregs
circulating during acute malaria infections almost exclusively
expressed an activated memory phenotype suggesting that they
have expanded from a pre-existing pool of memory T-cells. This
interpretation would be in line with recent elegant work in humans
demonstrating that Tregs are derived by rapid turnover of
memory populations in vivo [59], and with data from murine
studies where, after CD25-depletion, malaria infection very
rapidly drives differentiation of Tregs from circulating mature
CD4+ T cells [60]. Obviously, it would be of interest to study the
relationship between Tregs and effector T cell kinetics and parasite
biomass, which is not readily measurable. Future studies may
explore the usefulness of P. falciparum Histidine Rich Protein 2 in
this context, which has recently been suggested as a surrogate
marker for parasite biomass [61].
However, despite clear evidence of Treg induction and realloca-
tion during acute malaria infection, we could not find any robust
differences in Treg parameters between children with severe and
uncomplicated disease. Thus, neither Treg numbers nor FOXP3
mRNA levels differed significantly between children with uncompli-
cated malaria and those with severe malaria, and three different
indicators of Treg function - their capacity to suppress lymphopro-
liferation, their expression of SOCS-2 [45] and TNFR2 [46,48] were
all similar in severely ill children and children with uncomplicated
disease. Furthermore, the similar distortion in the T-BET/FOXP3
mRNA ratio during acute disease and the lack of any marked
differences between the two groups in ratios of inflammatory to anti-
inflammatory cytokines, as well as the close correlation between IFN-
c and IL-10 in both groups which is in line with previous observations
in experimental human malaria infections [62], suggests that the
systemic shift towards a pro-inflammatory immune response is similar
in children with either severe or uncomplicated disease.
At first glance, these data do not appear to support the
hypothesis that deficiencies in Treg function underlie the tendency
of some children to develop severe, life threatening malaria.
However, we did observe significantly higher Th1 effector
responses (more T-effector cells, higher concentrations of IFN-c
and TNF-a) in severely ill children than in children with
uncomplicated disease, suggesting that the classical FOXP3+ Treg
response that develops during acute malaria infection may be
insufficient to balance the florid effector T cell response that
develops particularly in children with severe disease. This would
be in line with evidence showing that as the strength of the
Figure 5. Ratios of Th1 over Treg cells and pro-inflammatory over regulatory cytokines. (A) Ratio of the mRNA level of the Th1
transcription factor T-BET over FOXP3 for uncomplicated and severe cases during the acute phase (D0) and convalescence (D28) as determined by RT-
PCR. Plasma levels for (B) IFN-c, (C) TNF-a, and (D) IL-10 measured with a bioplex system and the ratios of (E) IFN-c/IL-10 protein as well as (F) TNF-a/
IL-10 protein on day 0. (NB: Protein ratios could not be calculated for Day 28, since cytokine concentrations were rarely above the detection limit of
the assay. In Figure 5E and 5F only ratios for samples that had detectable responses for both cytokines on Day 0 are shown) Symbols, bars and p-
values as defined in Figure 1.
doi:10.1371/journal.ppat.1000364.g005
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Figure 6. Phenotypic characterization of cytokine-producing cells. PBMC from 30 children with acute P. falciparum infection were cultured
with growth medium (GM) or pulsed with PMA and Ionomycin (P/I) for 5 hours and assessed for the production of IL-10 and IFN-c by flowcytometry.
(A) representative example of PBMC stained with isotype control (left panel) or anti- IL-10 and anti-IFN-c (right panel). (B) Representative example of
the phenotype of IL-10 producing cells. (C) Proportion of IL-10 producing cells. The geometric mean with CI95% is shown. (D) Representative example
of co-staining for IL-10 and FOXP3 (left panel) or CD25 (right panel). Across all samples tested, 0.13% (median; CI 95%: 0.09–0.16%) of PBMC stained
positively for both IL-10 and FOXP3, corresponding to 2.4% (median; CI95%: 1.7–4%) of IL-10 producing cells being FOXP3+. Approx 0.79% (median;
CI95%: 0.69–1.1%) of CD3+CD4+ PBMC were IL-10+ and CD25+, corresponding to a 8.68% (median; CI 95%: 4.9–9.8%) of IL-10+T cells being CD25+. (E)
Representative example of co-staining for IFN-c and FOXP3. Across all samples tested, 0.29% (median; CI 95%: 0.21–0.37%) of PBMC stained positively
for both IFN-c and FOXP3, corresponding to 0.97% (median; CI95%: 0.67–1.27%) of IFN-c producing cells being FOXP3+. (F) Percentage of IL-10 single
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inflammatory stimulus increases, the suppressive capacity of
human Tregs declines and the resistance of T-effector cells to
regulation increases [63]. The situation observed during an acute,
clinical malaria infection is thus in clear contrast to the situation in
healthy, malaria-exposed individuals where Treg numbers closely
track numbers of T-effectors, precisely maintaining an apparently
optimal T-effector:Treg ratio [36].
IL-10 is well-established as a vital homeostatic regulator of
malaria-induced inflammation that prevents immune-pathology in
mice [49,64], promotes the necessary switch from early Th1 to
subsequent Th2 responses [65,66], and has been linked to protection
from severe malaria anaemia [24,25], and death [23] in humans.
However, the cellular source of IL-10 in human malaria cases was,
until now, ill defined. Contrary to our expectations, but in striking
agreement with observations in P. yoelii-infected mice [33],
CD45RO+ CD4+ T cells (that are CD252 and FOXP32) and not
classical Tregs are the only substantial source of IL-10 during acute
malaria infection. This observation is reminiscent of that made by
Nylen [67] in patients with acute visceral leishmaniasis. Moreover,
in our patients, a significant proportion of IL-10 producing CD4+ T
cells were simultaneously producing IFN-c, identifying them as Th1
cells. Although IL-10 secreting Th1 cells have been described
recently in two murine models of toxoplasmosis [50], and cutaneous
leishmaniasis [51], as far as we are aware, this is the first
demonstration of IL-10 producing Th1 cells during human
infections. Intriguingly, the proportion of these cells within the total
CD4+ T cell population was significantly higher in children with
uncomplicated malaria than in children with severe malaria
suggesting that in human P. falciparum infection, as in murine
T.gondii infections [50], IL-10 producing Th1 cells, activated by a
strong inflammatory stimulus, may act as anti-parasitic effector cells
with a ‘‘built in’’ control mechanism to prevent the onset of immune
pathology. If so, then the ability of these self-regulating effector cells
to localize to sites of parasite sequestration in tissues, where they
mediate parasite killing whilst simultaneously blocking tissue
damage, may be key to clinical immunity to malaria. Thus, our
data strongly suggest that the percentage of IL-10-producing Th1
effector cells, rather than the cocktail of circulating cytokines, may be
the most relevant biomarker of effective immunity to severe malaria.
Although Tregs may not seem to determine the outcome of
current P. falciparum infections we did find evidence that they affect
the magnitude of the malaria specific memory response induced
by the current infection. A similar observation has been made in P.
berghei ANKA-infected mice; animals that were depleted of CD25+
cells prior to infection and drug-cured on day 5 developed
significantly stronger IFN-c memory responses on day 14 than did
intact infected/cured mice, and these mice also developed much
more severe, and frequently fatal, clinical symptoms upon
reinfection, despite more efficient parasite clearance [35]. Thus,
malaria specific Tregs acquired during a primary infection may
limit the magnitude of Th1 effector responses to subsequent
infections to a level that allows parasite clearance without causing
immunopathology. Future studies should be designed to test the
hypothesis that Tregs may contribute to the very rapid
development of resistance to severe malaria.
In summary, our data indicate that classical FOXP3+ Tregs are
unable to control the florid inflammation that accompanies acute
malaria infections and this component of the immunoregulatory
arsenal is rapidly overwhelmed in children with either mild or severe
malaria. Importantly however we have identified, for the first time in
an acute human infection, a population of IL-10 producing Th1
effector cells which appear to be a major source of this key anti-
inflammatory cytokine during acute malaria infection, and which are
associated with development of uncomplicated as opposed to severe
malaria. We propose that IL-10-producing Th1 cells may be the
essential regulators of acute infection-induced inflammation and that
such ‘‘self-regulating’’ Th1 cells may be essential for the infection to
be cleared without inducing immune-mediated pathology. More-
over, we have found evidence in support of the hypothesis that Tregs
limit the magnitude of the Th1 memory response raising the
intriguing possibility that they may play an important role in the
rapid evolution of clinical immunity to severe malaria.
Materials and Methods
Subject recruitment, study design, and study procedures
A case-control study was conducted in Gambian children with
severe or uncomplicated malaria, resident in a peri-urban area
within a 40 km radius south of the capital, Banjul, with low levels of
malaria transmission [68,69]. Patients were enrolled at Brikama
Health Centre, the MRC Fajara Gate Clinic or the Jammeh
Foundation for Peace Hospital in Serekunda between September
2007 and January 2008, after written informed consent was obtained
from the parents or guardians. Uncomplicated disease was defined as
an episode of fever (temperature .37.5uC) within the last 48 hours
with more than 5000 parasites/ml detected by slide microscopy.
Severe disease was defined using modified WHO criteria [70]: SA,
defined as Hb,6 g/dl; SRD defined as serum lactate .7 mmol/L;
CM defined as a Blantyre coma score #2 in the absence of
hypoglycaemia, with the coma lasting at least for 2 hours. To avoid
the confounding effects of other pathogens in children with
concomitant systemic bacterial infections [71], children with clinical
and/or laboratory evidence of infections other than malaria were not
enrolled into the study. For some experiments, healthy children of
the same age and recruited from the same area at the same time of
the year were enrolled as controls. In total, 59 severe, 65
uncomplicated and 20 control cases were enrolled.
On admission (D0) and after 4 weeks (D2863 days) one ml of
blood was collected in RNA stabilizing agent (PAXgeneTM Blood
RNA system, Pre-AnalytiX) and a maximum of 4 mls of blood
(mean: 3.2 mls CI 95%: 3.1–3.3 mls) were collected into
heparinized vacutainersH (BD). All patients received standard
care according to the Gambian Government Treatment Guide-
lines, provided by the health centre staff. The children’s health was
reviewed 7 days after admission. The study was reviewed and
approved by the Joint Gambian Government/MRC Ethics
Committee and the Ethics Committee of the London School of
Hygiene & Tropical Medicine (London, UK).
P. falciparum parasites were identified by slide microscopy of 50
high power fields of a thick film. Full differential blood counts were
obtained on days 0 and 28 using a MedonicTM instrument (Clinical
Diagnostics Solutions, Inc); the presence of intestinal helminths was
assessed by microscopy from stool samples collected into BioSepar
ParasiTrapH diagnosis system, following the manufacturers’ in-
structions. Sickle cell status was determined by metabisulfite test and
confirmed on cellulose acetate electrophoresis [72].
positive, IFN-c single positive, and IL-10/IFN-c double positive CD4+ T cells from 17 children with severe (open bars) and 13 children with
uncomplicated (shaded bars) malaria are shown. PBMC were activated with P/I for 5 hours prior to staining. (G) The percentage of IFN-c producing
CD4+ T cells co-producing IL-10, as well as the percentage of IL-10 producing CD4+ T cells co-producing IFN-c is shown for severe (open bars) and
uncomplicated (shaded bars) cases. Bars in (F) and (G) represent the geometric mean with 95% CI.
doi:10.1371/journal.ppat.1000364.g006
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Cell preparation
Blood samples were processed within 2 hours of collection.
Plasma was removed, stored at 280uC and replaced by an equal
volume of RPMI 1640 (Sigma-Aldrich). PBMC were isolated after
density centrifugation over a 1.077 Nycoprep (Nycomed, Sweden)
gradient (800 g, 30 min) and washed twice in RPM 1640. Cells
were either stained for flow cytometry directly ex-vivo, or cultured
in RPMI 1640 containing 10% human AB+ serum, 100 mg/ml
streptomycin, 100 U/ml penicillin (all Sigma-Aldrich), and 2 mM
L-glutamine (Invitrogen Life Technologies), referred to as
complete growth medium (GM).
Flow cytometry
Fresh PBMC were stained using the following fluorochrome
labeled mouse or rat anti-human antibodies: FITC anti-TNF-
receptor II (R&D), PE anti-FOXP3 (clone PCH101), Pacific Blue
anti CD3, APC-Alexa Fluor 750 anti-CD127 (all Ebioscience),
APC anti-CD25, PerCP anti CD4 (BD systems), ECD anti-
CD45R0 (Beckman-Coulter), and appropriate isotype controls.
IL-10 and IFN-c production by PBMC from 30 children with
acute P. falciparum (D0) was assessed after 5 hours stimulation in
GM containing PMA (50 ng/ml) and Ionomycin (1000 ng/ml) or
GM alone.
Cells were stained with FITC anti-IFN-c, PE anti-FOXP3, PE-
Cy7 anti-CD25, APC-AF750 anti-CD8, Pacific Blue anti-CD3 (all
Ebioscience), PerCP anti-CD4, APC anti-IL-10 (both BD), and
ECD anti-CD45R0 (Beckman-Coulter). To ascertain specificity of
the intracellular cytokine staining, aliquots of some samples were
incubated with saturating amounts of purified non-labelled
antibody of the same clone prior to staining with the fluorochrome
labeled ICS antibody. The FOXP3 staining buffer set (Ebioscience)
was used following the manufacturer’s protocol. Samples were
acquired on a 3 laser/9 channel CyAnTM ADP flowcytometer using
Summit 4.3 software (Dako). Analysis was performed using FlowJo
(Tree Star Inc.). All flowcytometric analysis was performed at the
MRC laboratories, The Gambia on freshly isolated cells.
Multiplex analysis of plasma cytokine concentration
Plasma concentrations of IFN-c, TNF-a and IL-10 were
determined for each subject and time point on the Bio-PlexH 200
system, using X-PlexTM assays (both Bio-Rad Laboratories),
according to the manufacturer’s instructions. Data were analysed
using the Bio-PlexH Manager software. The detection limit was
defined as the concentration corresponding to a fluorescence value
above the mean background fluorescence in control wells plus 3 SD,
being 8.76 pg/ml for IFN-c, 5 pg/ml for TNF-a and 0.57 pg/ml
for IL-10. Values below this threshold were set to these levels.
Plasmodium falciparum culture and schizont antigens
P. falciparum parasites (3D7 strain) were cultured in vitro as
described [73] and were routinely shown to be mycoplasma free by
PCR (Bio Whittaker). Schizont-infected erythrocytes were harvest-
ed from synchronized cultures by centrifugation through a Percoll
gradient (Sigma-Aldrich). PfSE was prepared by two rapid freeze-
thaw cycles in liquid nitrogen and a 37uC water bath. Extracts of
uninfected erythrocytes (uRBC) were prepared in the same way.
Proliferation assay
PBMC from 10 severe and 10 uncomplicated malaria cases
collected on day 0 were depleted of CD25hi cells or mock depleted
using magnetic beads (Dynal Biotech, UK), at a bead to PBMC
ratio of 7:1, and cell proliferation was determined by [3H]-
thymidine (Amersham, UK) incorporation after 6 days in culture
Figure 7. Tregs induced during the clinical episode under study
limit the magnitude of subsequent malaria-specific IFN-c
memory responses. (A) PBMCs collected on day 28 were cultured
for 6 days with PfSE, uRBC, P+I or GM, respectively, and assayed in an
IFN-c ELISpot to measure the magnitude of the malaria specific memory
response. Background levels of IFN-c production obtained in uRBC or
GM were deducted from PfSE or PI. (B) cultured IFN-c ELISpot responses
to PfSE (D 28) are plotted against FOXP3 mRNA levels measured on day
0. A linear by linear hyperbolic fit revealed a significant association
(p = 0.009). +: severe cases; #: uncomplicated cases. Scattered lines
indicate the 95% CI limits. At the 5% level there is no significant
improvement in fit, using separate lines for severe and uncomplicated
patients. No significant effect of parasitaemia could be observed.
Depending on a parasitaemia level above or below the median
parasitaemia in both groups, a diamond (high) or a square (low) was
added to individual data points to illustrate this.
doi:10.1371/journal.ppat.1000364.g007
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with PfSE, uRBC (RBC:PBMC ratio equivalent to 2:1), GM, or 2
days culture with PMA (10 ng/ml)+ Ionomycin (100 ng/ml), as
described [27].
Cultured ELISpot
Cultured ELISPOTs were performed to assess malaria specific
IFN-c memory responses, adapting an established method [74].
Up to 1 million PBMCs collected on day 28 were cultured in 24
well plates for 6 days in 1 ml GM and stimulated with either PfSE,
uRBC (RBC:PBMC ratio equivalent to 2:1), or GM respectively.
At day 3, half the medium was exchanged and rIL-2 (final
concentration 20 IU/well) was added. On day 6 cells were
harvested, washed three times, and 1.56105 cells seeded into
duplicate wells onto Millipore MAIP S45 plates and restimulated
overnight with PfSE, uRBC (concentrations as above), GM or
PHA-L (5 mg/ml). IFN-c ELISpot was performed using MabTech
antibodies according to the manufacturer’s instructions. Spot
forming cell numbers were counted using an ELISPOT plate
reader (AutoImmuneDiagnostica, Vers. 3.2). Results are expressed
as spot forming units (SFU) per million PBMC after subtraction of
individual background values (GM for PHA-L, uRBC for PfSE)
being deducted. Assays were discounted if the positive control
(PHA-L) was ,50 SFU, or the negative control was .30 SFU.
RT-PCR
For quantitative reverse transcription-polymerase chain reac-
tion (RT-PCR), total RNA was extracted from PAX tubes
following the manufacturer’s instructions and reverse transcribed
into cDNA using TaqManH reagents for reverse transcription
(Applied Biosystems), following the manufacturer’s protocol. Gene
expression profiles for FOXP3, IL-10, SOCS-2 and IFN-c were
measured by RT-PCR on a DNA Engine OpticonH (MJ Research)
with QuantiTect SYBR Green PCR kits (Qiagen Ltd) using
primers (all Sigma Genosys) previously described: IFN-c, IL-10;
FOXP3 designed by [75], and SOCS-2 designed by [76].
T-BET and GATA-3 gene expression was determined using the
TaqManH Probe kit using the primers (all Metabion) designed by
[77]. 18S rRNA, amplified using a commercially available kit
(rRNA primers and VIC labeled probe, Applied Biosystems), was
used as an internal control. Data were analysed using Opticon
Monitor 3TM analysis software (BioRad) and are expressed as the
ratio of the transcript number of the gene of interest over the
endogenous control, 18S rRNA.
Parasite genotyping
Genomic DNA from each parasite isolate was genotyped by
sequencing the highly polymorphic block 2 region of the msp1 gene
to assess the number of clones infecting each patient [78].
Statistical analysis
Analysis was performed using linear regression, with a random
effect to allow for the within subject measurements over time,
where the response variables were log transformed to improve the
normality and constant variance assumptions. Significance
(measured at the 5% level) tests for the effects of malaria group
(uncomplicated, SA or SB), time (day 0 and day 28) and their
interaction were adjusted for the possible confounding effects of
age, sex, duration of prior symptoms and numbers of clones
causing the infection. Where there was no significant malaria
group and time interaction, p-values for the overall comparison of
day 0 vs. day 28 are given. Within day 0, comparisons of severe vs.
uncomplicated and the two groups of severely ill patients (SA vs SB)
were adjusted for any malaria group and time interactions. To
allow for the multiplicity of tests resulting from multiple responses
and multiple comparisons within a response performed in the
model, a false discovery rate (FDR) of 5% was assumed. Using the
Benjamini and Hochberg approach [43] only tests with a p-value
below 0.012 have an FDR of #5%. Due to the large number of
tests family-wise error rate correction methods were too conser-
vative. Analyses were performed using Stata version 9 and Matlab
version R2008a.
Supporting Information
Figure S1 mRNA levels for IFN-c, IL-10 and Th-1 as well as
Th-2 lineage transcription factors in severe and mild disease.
Found at: doi:10.1371/journal.ppat.1000364.s001 (1.99 MB TIF)
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